NCT04159116

Brief Summary

The purpose of this study is to identify patient and provider-chosen factors that put patients at risk for the development of hypoxemia (oxygen saturation \< 90% for 5 seconds) during endoscopy and to use this knowledge to develop a treatment protocol for specific causes of hypoxemia in adult esophagogastroduodenoscopy outpatients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2019

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 12, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 19, 2020

Completed
Last Updated

March 17, 2021

Status Verified

March 1, 2021

Enrollment Period

5 months

First QC Date

November 7, 2019

Last Update Submit

March 16, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of laryngospasm during EGDs

    Determine if prophylactic suctioning after sedation but prior to introduction of endoscope changes the incidence of laryngospasm during EGDs.

    2 hours

  • Identify risk factors for the development of hypoxemia during EGD

    These risk factors include both patient factors (ASA class, history of cardiopulmonary disease, BMI, social history, Obstructive Sleep Apnea, STOP-BANG scores and age) and provider-chosen factors (medications given, airway interventions, percent and flow of oxygen in liters per minute, and whether or not the patient was suctioned prior to or during the procedure).

    2 hours

Secondary Outcomes (2)

  • Incidence of copious secretions, choking, desaturation, and shortened or aborted procedures

    2 hours

  • Identify the various causes of hypoxemia during EGD

    2 hours

Study Arms (2)

Suctioned Prior to Endoscope

EXPERIMENTAL

This group will be suctioned prophylactically after sedation but prior to introduction of endoscope.

Other: Prophylactic suctioning when clinically indicated

Standard of Care

OTHER

This group will be suctioned by anesthesia providers when clinically indicated by copious secretions, coughing, choking or desaturation.

Other: Prophylactic suctioning when clinically indicated

Interventions

Suctioned prophylactically when clinically indicated by copious secretions, coughing, choking or desaturatation

Standard of CareSuctioned Prior to Endoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over the age of 18 years
  • English speaking
  • Mentally competent to sign their own consent for treatment

You may not qualify if:

  • Poor incisor teeth stability
  • Anticipated procedure of greater than 30 minutes
  • History of facial or oral surgery and a baseline oxygen saturation of less than 95% on room air

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Three Rivers Endoscopy

Moon Township, Pennsylvania, 15108, United States

Location

MeSH Terms

Conditions

LaryngismusHypoxia

Condition Hierarchy (Ancestors)

Vocal Cord DysfunctionLaryngeal DiseasesRespiratory Tract DiseasesRespiration DisordersOtorhinolaryngologic DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Suzanne Morrison, DNP, CRNA

    Envision Healthcare

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2019

First Posted

November 12, 2019

Study Start

November 4, 2019

Primary Completion

March 19, 2020

Study Completion

March 19, 2020

Last Updated

March 17, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations